Voriconazole BA study [Design Issues]

posted by Rajdeep  – New Delhi, India, 2007-11-05 12:46 (6810 d 14:14 ago) – Posting: # 1282
Views: 6,185

❝ ... do you have anything particular in mind which might complicate

❝ the design?


Dear Sir

The particular thing which I am worried about is the effect of the non-linear pharmacokinetics of Voriconazole that might upset the design. So the question is whether there might be suitable parameters that can be followed inorder to cut-down the above variation in the study trial. That's the thing that makes me ask for similar articles featuring a study design on the above drug.

regards
Rajdeep.

--
Edit: Full quote removed. Please see this post! [HS]
—
Best regards
Rajdeep Mukherjee
Protocol Developer

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
302 visitors (0 registered, 302 guests [including 15 identified bots]).
Forum time: 04:00 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5